International PharmaceuticalProducts Inc said Eli Lilly and Co has filed a patentinfringement suit against it for marketing Vincristine Sulfatefor injection.    International Pharmaceutical said it believes that becaueof differences in formulation, it is not infringing on EliLilly's patent.    Vincristine Sulfate is a chemotherapeutic product used totreat cancer. Reuter&#3;